Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Oral Abstract Session 01 - Global HIV Vaccine Enterprise
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
POSTERS<br />
Posters<br />
Topic 7: Innate Immunity<br />
P07.13<br />
Early Immune Events During Acute <strong>HIV</strong> Infection<br />
B.M. Slike 7 , B. Tassaneetrithep 1 , S. Nitayaphan 2 , K. Rono 3 ,<br />
E. Sanga 4 , A. Sekiziyivu 5 , D. Stablein 6 , L. Eller 7 , M.A. Eller 7 ,<br />
J. Kim 7 , N. Michael 7 , M. Robb 7 , M. Marovich 7<br />
1 Siriraj Hospital, Mahidol University, Bankok, Thailand; 2 Armed<br />
Forces Research Institute of Medical Sciences, Bankok,<br />
Thailand; 3 Walter Reed Program, Kericho, Kenya; 4 Mbeya<br />
Medical Research Programme, Mbeya, United Republic of<br />
Tanzania; 5 Makerere University Walter Reed Project, Kampala,<br />
Uganda; 6 Emmes Corporation, Rockville, MD, USA; 7 US Military<br />
<strong>HIV</strong> Research Program, Silver Spring, MD, USA<br />
Background: We characterized plasma cytokine and chemokine<br />
profiles at baseline and during acute infection in a prospective<br />
high-risk cohort (RV217). PBMC collected in parallel allow for the<br />
longitudinal analysis of changes in immune cell populations during<br />
acute infection. These data can provide insight into the earliest<br />
events in host-<strong>HIV</strong> interaction and inform <strong>HIV</strong> vaccine development.<br />
Methods: Semiweekly viral load (VL) testing in individuals at highrisk<br />
for <strong>HIV</strong> acquisition was performed to prospectively identify<br />
very early acute <strong>HIV</strong> infections (Fiebig stage I/II, NAT+/Ab-).<br />
Cytokines were assayed in plasma from pre-infection through<br />
early plasma viral load set point using the Q-Plex Multiplex Array<br />
or by traditional ELISA. Peripheral blood cells were longitudinally<br />
analyzed with multiparameter flow cytometry.<br />
Results: African participants were all female and acquired subtype<br />
A, C and D recombinant <strong>HIV</strong> while participants in Thailand were<br />
male and acquired <strong>HIV</strong> subtype E predominantly. Longitudinal<br />
plasma samples from acutely infected individuals (n=24) showed<br />
similar trends in cytokine profiles with statistically significant<br />
increases in expression over time. VL setpoint, IL-10 and MCP-1<br />
expression differed by region. Preliminary PBMC analysis revealed<br />
frequency and phenotypic changes in all antigen presenting cell<br />
populations. Significant decreases in plasmacytoid dendritic cells<br />
were observed at peak VL, which preceded a sharp decline in<br />
plasma IFN-α to near baseline values. MCP-1 and IP-10 also rose<br />
sharply in conjunction with fluctuations in T cell subsets and<br />
APCs. These early changes could impact adaptive cellular and<br />
humoral immune responses.<br />
Conclusion: Understanding cytokine kinetics and VL dynamics<br />
during acute <strong>HIV</strong> infection may help identify key controls<br />
of early viral set point. Regional differences may reflect <strong>HIV</strong><br />
subtype, gender, background cytokine expression levels and<br />
co-morbidities as these covaried. Analyses of correlations<br />
with immune cell phenotype/function and viral set point are<br />
underway. Efforts focus on examination of the evolution of the<br />
innate response after infection, prior to peak viremia.<br />
186<br />
AIDS <strong>Vaccine</strong> 2<strong>01</strong>2<br />
P07.14 LB<br />
Modulation of <strong>HIV</strong>-1 Replication In Primary Dendritic<br />
Cells In Contact With Autologous CD4 T-Lymphocytes<br />
B. Su 1 , M.E. Biedma 1 , A. Lederle 1 , M. Lambotin 1 , C. Moog 1<br />
1 INSERM U748, Université de Strasbourg, Strasbourg, France<br />
Background: Immature dendritic cells (DCs), which reside in<br />
genital mucosal surfaces, are among the first cells that encounter<br />
<strong>HIV</strong>-1. These cells poorly replicate R5-tropic <strong>HIV</strong>-1, but have<br />
been shown to efficiently transfer the virus to autologous CD4<br />
T-lymphocytes. We have shown that <strong>HIV</strong>-1 replication was<br />
enhanced in primary <strong>HIV</strong>-1-loaded DCs when they are in close<br />
contact with autologous CD4 T-lymphocytes. Recently, SAMHD1<br />
has been proposed to restrict <strong>HIV</strong>-1 replication in myeloid cells by<br />
decreasing deoxynucleoside triphosphate (dNTP) pools. We aimed<br />
to decipher whether SAMHD1 was involved in the increased <strong>HIV</strong>-<br />
1 replication observed in DCs coculture with CD4 T-lymphocytes.<br />
Methods: DCs were generated from human blood CD14 +<br />
monocytes. After 2 hours of incubation with <strong>HIV</strong>-1, DCs were<br />
added to autologous primary CD4 T-lymphocytes. The percentage<br />
of infection was quantified by flow cytometry (intracellular p24<br />
staining). The expression of intracellular SAMHD1 was measured<br />
by flow cytometry and by western blot. Virus-like particles<br />
containing Vpx (VLP-Vpx) was used as control to decrease<br />
SAMHD1 expression.<br />
Results: <strong>HIV</strong>-1 replication was enhanced in DCs cocultured<br />
with autologous CD4 T-lymphocytes compared to DCs alone.<br />
Slightly lower levels of SAMHD1 expression were detected in<br />
infected cocultured DCs by flow cytometry. Moreover, addition<br />
of exogenous dNTPs to the culture significantly increased <strong>HIV</strong>-1<br />
replication in DCs. As control, VLP-Vpx enhanced viral replication<br />
and decreased SAMHD1 expression in DCs.<br />
Conclusion: Preliminary results suggest that the stimulation of<br />
<strong>HIV</strong>-1 replication in DCs observed in coculture conditions was<br />
partially associated to the concomitant decrease of SAMHD1<br />
expression in DCs. As <strong>HIV</strong>-1 replication was inhibited by Abs<br />
in DCs, further investigations are required to determine if<br />
SAMHD1 modulates <strong>HIV</strong>-1 replication in the presence of these<br />
Abs. Cross-links between the restriction factors and humoral<br />
immune response should be considered in the development of<br />
an effective anti-<strong>HIV</strong>-1 vaccine.